<--- Back to Details
First PageDocument Content
Clinical Data Management / Pharmacology / Drug discovery / Pharmaceutical industry / Critical Path Institute / Patient-reported outcome / Clinical trial / Electronic patient-reported outcome / Mpro / Research / Clinical research / Pharmaceutical sciences
Date: 2014-12-12 12:42:08
Clinical Data Management
Pharmacology
Drug discovery
Pharmaceutical industry
Critical Path Institute
Patient-reported outcome
Clinical trial
Electronic patient-reported outcome
Mpro
Research
Clinical research
Pharmaceutical sciences

Job Title: Department: Reports to: FLSA Status: Location:

Add to Reading List

Source URL: c-path.org

Download Document from Source Website

File Size: 106,09 KB

Share Document on Facebook

Similar Documents

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

DocID: 1voSH - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

DocID: 1vnKo - View Document

Scientific Program conferenceseries.com 3rd International Conference and Expo on Drug Discovery & Designing

DocID: 1vngF - View Document

5th CDDD Meeting COMPUTATIONALLY DRIVEN DRUG DISCOVERY November 16-17, 2017 | IFOM, Milan - Italy

DocID: 1vkVj - View Document